Kite Pharma | Company Profile
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Social & Marketing
Video & Media
Keywords & Focus Areas
Kite Pharma
Overview
Kite Pharma is a biotechnology company based in Santa Monica, California, specializing in cancer immunotherapy. Founded in 2009, it focuses on developing genetically engineered autologous CAR T cell therapies. As a subsidiary of Gilead Sciences since 2017, it has enhanced its capabilities in advancing cell therapy research and commercialization.
The organization is recognized for its pioneering work in immuno-oncology, especially through its flagship products Yescarta® and Tecartus®. Yescarta® is the first FDA-approved CAR T therapy for adult patients with relapsed or refractory large B-cell lymphoma, while Tecartus® serves patients with certain blood cancers, including mantle cell lymphoma. Kite Pharma maintains a robust research pipeline and numerous collaborations to advance cell therapy innovation. With manufacturing facilities located worldwide, including a major site near Amsterdam, the company delivers innovative therapies to adult and pediatric patients with hematologic malignancies.
Basic Information
| Industry | research, biotechnology |
|---|---|
| Founded | 2009 |
| Revenue | 550M |
| Headquarters | 2400 Broadway, Santa Monica, California 90404, United States |
| Languages | English |
| Parent Organization | Gilead Sciences |
Contact Details
- Phone: +1 310-824-9999
- Website: kitepharma.com
- LinkedIn: linkedin.com/company/kite-pharma-inc-
- AngelList: angel.co/kite-pharma
- Twitter: twitter.com/kitepharma
Key Focus Areas & Initiatives
- CAR T-cell therapy development
- Immunotherapy research
- Personalized medicine for cancer treatment
- Cell therapy clinical trials
- Manufacturing process innovation
- Targeted therapies for hematologic malignancies
- FDA-approved therapies
- Collaborations in cancer research
- Autologous CAR T cells
- Cell engineering technology
- Solid tumor therapies
- Patient outcomes and safety
- Advanced therapy designation
Technologies Used
- ASP.NET
- CSC Corporate Domains
- CloudFlare CDN
- CloudFlare Hosting
- Facebook Custom Audiences
- Facebook Login (Connect)
- Facebook Widget
- Google Analytics
- Google Tag Manager
- Linkedin Marketing Solutions
- Microsoft Azure Hosting
- Microsoft Office 365
- Mobile Friendly
- OneTrust
- Remote
- Ruxit
- SiteCore
- Typekit
- Workday
- YouTube
Community
